まとめ
高齢の患者の脳腫瘍に対する頭蓋骨切開はしばしば実行可能ですが,慎重に患者の選択と管理を行うことが重要です. 多くの方が改善する一方で,合併症や悪化などの外科リスクは個別化されたケアを必要とします.
科学分野:
- 神経外科は神経外科です.
- ゲリアトリック・メディシン (老年医学)
- 腫瘍学 腫瘍学
背景:
- 脳腫瘍は高齢者にとって大きな懸念事項である.
- これらの患者にとって,クレニオトミーが潜在的な治療の選択肢です.
- 脳外科手術を受けた高齢者の結果と合併症は,特に考慮する必要があります.
研究 の 目的:
- 65歳以上の患者の脳腫瘍に対する頭蓋骨切開の結果を評価する.
- この集団における一般的な腫瘍タイプと術後の合併症を特定する.
- 高齢の神経外科患者の手術介入の有効性とリスクを評価する.
主な方法:
- 脳腫瘍のために頭蓋骨切除を受けた65歳以上の80人の患者の遡及的分析.
- 腫瘍の種類,手術の結果,手術後の合併症に関するデータ収集.
- グリオブラストーマ,転移性がん,髄膜腫を含む腫瘍の分類.
主要な成果:
- グリオブラストーマが最も頻繁に診断され,次に転移性がんと髄膜腫が続いた.
- 30日間の死亡率は低かった (3患者).
- 術後の全身的な合併症は23人の患者で発生し,主に肺の問題でした. 44%が著しく改善し,21%が悪化した.
結論:
- 脳腫瘍に対する頭蓋骨切開は,一般的に高齢の患者で手術可能である.
- 手術の徴候は,腫瘍の種類と患者の状態に基づいて個別化されなければならない.
- 術前および術後管理の強化は,全身的な合併症を軽減し,結果を最適化するために不可欠です.
関連する概念動画
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


